Since SGOT/SGPT ratio is increased in non alchoholic steatohepatitis (NASH), we speculate role of 11 β HSD1 activity as determining factor in fatty liver to NASH progression. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.